2023
DOI: 10.3390/cancers15215179
|View full text |Cite
|
Sign up to set email alerts
|

Integrating [18F]-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors

Conor M. Prendergast,
Egesta Lopci,
Romain-David Seban
et al.

Abstract: [18F]-FDG positron emission tomography with computed tomography (PET/CT) imaging is widely used to enhance the quality of care in patients diagnosed with cancer. Furthermore, it holds the potential to offer insight into the synergic effect of combining radiation therapy (RT) with immuno-oncological (IO) agents. This is achieved by evaluating treatment responses both at the RT and distant tumor sites, thereby encompassing the phenomenon known as the abscopal effect. In this context, PET/CT can play an important… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…The potential clinical relevance of ImmunoPET is undeniable because the immune system and the components of the TME are renowned predictive and prognostic factors of treatment benefits and patient outcomes, limited not only to immunotherapy but also to other regimens. Of particular interest is the synergic effect of combining radiation therapy (RT) with immunomodulatory agents and the expected abscopal effect, which can be explained as being mainly based on immune-mediated component activation, leading to cancer-cell death at distant sites from radiation [53]. Furthermore, the complementary use of ImmunoPET with metabolic imaging could maximize the ability to characterize tumor tissues and assess their responsivity to specific treatments, even more emphasized by the advent of texture analyses and artificial intelligence (AI) [54] in image interpretations.…”
Section: Discussionmentioning
confidence: 99%
“…The potential clinical relevance of ImmunoPET is undeniable because the immune system and the components of the TME are renowned predictive and prognostic factors of treatment benefits and patient outcomes, limited not only to immunotherapy but also to other regimens. Of particular interest is the synergic effect of combining radiation therapy (RT) with immunomodulatory agents and the expected abscopal effect, which can be explained as being mainly based on immune-mediated component activation, leading to cancer-cell death at distant sites from radiation [53]. Furthermore, the complementary use of ImmunoPET with metabolic imaging could maximize the ability to characterize tumor tissues and assess their responsivity to specific treatments, even more emphasized by the advent of texture analyses and artificial intelligence (AI) [54] in image interpretations.…”
Section: Discussionmentioning
confidence: 99%